Recent advances in small interfering RNA sensing by the immune system

New Biotechnology

Volumn 27, Issue 3, 2010, Pages 236-242

  Sioud, Mouldy ^a  

^a Center of Clinical Epidemiology   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONAL GENOMICS; GENE SILENCING; IMMUNE RECEPTORS; IMMUNE SYSTEMS; MICRORNAS; NEW STRATEGY; PROCESSING MACHINERY; RNA INTERFERENCE; SENSING RECEPTORS; SMALL INTERFERING RNA; THERAPEUTIC AGENTS;

COMPETITION; GENETIC ENGINEERING; IMMUNOLOGY; MACHINERY; STRATEGIC PLANNING;

RNA;

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; BETA INTERFERON; C TYPE LECTIN RECEPTOR; CYTOSOL RECEPTOR; INTERLEUKIN 5; LECTIN RECEPTOR; LIGAND; MYXOVIRUS RESISTANCE PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE L; SINGLE STRANDED DNA; SINGLE STRANDED RNA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

CELL ACTIVATION; CHEMICAL MODIFICATION; ENZYME ACTIVATION; ENZYME SUBSTRATE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC PROCEDURES; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; GENE SILENCING; HUMANS; IMMUNITY, INNATE; MICRORNAS; MOLECULAR STRUCTURE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTORS;

EID: 77952955053     PISSN: 18716784     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbt.2010.02.015     Document Type: Review

References (35)

1. Fire A., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
2. Malone C.D., et al. Small RNAs as guardians of the genome. Cell 136 (2009) 656-668
3. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55 (2001) 255-281
4. Matranga C., et al. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123 (2005) 607-620
5. Rand T.A., et al. Wang: Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123 (2005) 621-629
6. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
7. Hannon G.J., and Rossi J.J. Unlocking the potential of human genome with RNA interference. Nature 431 (2004) 371-378
8. Sioud M. Therapeutic siRNAs. Trends Pharmacol. Sci. 25 (2004) 22-28
9. Sioud M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol. Med. 12 (2006) 167-716
10. Janeway C.A., and Medzhitov Jr. R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
11. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 (2005) 1-14
12. Brennan C.A., and Anderson K.V. Drosophila: the genetics of innate immune recognition and response. Annu. Rev. Immunol. 22 (2004) 457-483
13. Lemaitre B., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
14. Li S., et al. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10005-10010
15. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
16. Kato H., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
17. Kato H., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005) 19-28
18. Meylan E., et al. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
19. Hornung V., et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
20. Kariko K., et al. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 172 (2004) 6545-6549
21. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348 (2005) 1079-1090
22. Hornung V., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
23. Judge A.D., et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
24. Sioud M. Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur. J. Immunol. 36 (2006) 1222-1230
25. Cekaite L., et al. Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects. J. Mol. Biol. 365 (2007) 90-108
26. Sioud M., and Sorensen D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312 (2003) 1220-1225
27. Diebold S.S., et al. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 36 (2006) 3256-3267
28. Morrissey D.V., et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23 (2005) 1002-1007
29. Flatekval G.F., and Sioud M. Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3 dioxygenease. Immunology 1 Suppl. (2009) e837-e848
30. Judge A.D., et al. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13 (2006) 494-505
31. Sioud M. RNA interference and innate immunity. Adv. Drug Deliv. Rev. 59 (2007) 153-163
32. Sioud M., et al. Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs. Biochem. Biophys. Res. Commun. 361 (2007) 122-126
33. Furset G., et al. Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands. Immunology 123 (2008) 263-271
34. Robbins M., et al. 2′-O-methyl-modified RNAs act as TLR7 antagonists. Mol. Ther. 15 (2007) 1663-1669
35. Furset G., and Sioud M. Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule. Biochem. Biophys. Res. Commun. 352 (2007) 642-649